Cellular automata, cancer resistance, tumor heterogeneity, adaptive therapy, AI-assistance, and more.
This week in MathOnco 241
This week in MathOnco 241
This week in MathOnco 241
Cellular automata, cancer resistance, tumor heterogeneity, adaptive therapy, AI-assistance, and more.